Resources from the same session
Quality of life in TSU-68 study: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline
Presenter: Byeong Seok Sohn
Session: Breast cancer
Resources:
Abstract
Prognostic and predictive impact of Ki67 expression in triple-negative breast cancer
Presenter: Wei Wang
Session: Breast cancer
Resources:
Abstract
Prognosis of multifocal/multicentric breast cancers
Presenter: Delphine Hequet
Session: Breast cancer
Resources:
Abstract
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Presenter: Changhoon Yoo
Session: Breast cancer
Resources:
Abstract
Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival by body weight and anti-drug antibody status
Presenter: Jin-Seok Ahn
Session: Breast cancer
Resources:
Abstract
Multicenter observational study of fulvestrant 500 mg in postmenopausal Japanese women with ER positive advanced or recurrent breast cancer after prior endocrine treatment (SBCCSG29 study)
Presenter: Kei Kimizuka
Session: Breast cancer
Resources:
Abstract
Invited discussant abstracts 59PD, 60PD, 61PD and 62PD
Presenter: Takayuki Iwamoto
Session: Breast cancer
Invited discussant abstracts 53O and 55O
Presenter: Rebecca Dent
Session: Breast cancer
Comparison of incidental radiation dose to axilla and internal mammary nodal area by conventional, 3DCRT, and IMRT technique in carcinoma of breast
Presenter: H B Govardhan
Session: Breast cancer
Resources:
Abstract